Abstract
China's national tuberculosis control program (NTP) provides free, first-line anti-tuberculosis (TB) drugs to pulmonary TB patients. This treatment regimen follows the World Health Organization's (WHO) guideline. The objective of this paper is to evaluate the current status of anti-TB drug use for newly diagnosed pulmonary TB inpatients treated in prefecture- and county-level designated hospitals. Three prefecture-level hospitals and nine county-level hospitals were selected for the study. All newly diagnosed pulmonary TB inpatient medical records from 2012 were reviewed and doubly examined by two national senior physicians. The rational use of anti-TB drugs was evaluated based on criteria in line with WHO's guideline. Of the 2,060 total treatment regimens for TB, 53.1 % were found to be rational (1093/2060). The percentages in prefecture-level and county-level hospitals were 50.3 % (761/1513) and 60.7 % (332/547), respectively. The difference between the two levels of hospitals was statistically significant (Chi-square value = 17.44, P < 0.01). The percentages of rational treatment regimens for first-time hospitalizations and for two or more hospitalizations were 59.5 % (983/1653) and 27.0 % (110/407), respectively, with a sta...Continue Reading
References
Jan 25, 2002·Annals of the New York Academy of Sciences·P D Davies
Feb 27, 2007·Lancet·Longde WangDaniel P Chin
Nov 18, 2009·Tropical Medicine & International Health : TM & IH·Qin LiuPaul Garner
Aug 20, 2010·BMC Public Health·Nadia ValinChristos Chouaid
Oct 19, 2011·The European Respiratory Journal·Marieke J van der WerfDavide Manissero
Oct 19, 2011·The European Respiratory Journal·M W LangendamD Manissero
Jan 27, 2012·BMC Health Services Research·Guanyang ZouQiang Sun
Sep 7, 2012·PloS One·Chen-Yuan ChiangKuan-Jen Bai
Feb 22, 2013·BMC Infectious Diseases·Xiaolin WeiQiang Sun
Apr 18, 2013·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Li-Mei RanYou-Mei Feng
Jun 14, 2013·Journal of Pharmacology & Pharmacotherapeutics·Dhriti K BrahmaMarlina Ch Sangma
Oct 15, 2013·Journal of Evaluation in Clinical Practice·George MalaMark Spigt
Mar 14, 2014·PloS One·Xiaolin WeiQiang Sun
Mar 22, 2014·Lancet·Lixia WangYu Wang
Jun 26, 2014·Pharmacoepidemiology and Drug Safety·Shiow-Ing WangShang-Jyh Chiou
Aug 21, 2014·Global Health Action·Biao XuVinod K Diwan
Sep 27, 2015·Global Health Action·Guanyang ZouXiaolin Wei
Citations
Jan 30, 2016·Infectious Diseases of Poverty·Shenglan TangDaniel P Chin
Dec 19, 2017·Frontiers in Cellular and Infection Microbiology·Jia-Ni XiaoYing Wang
Aug 3, 2019·Infectious Diseases of Poverty·Yan-Jiao XinFei Huang